C-Reactive Protein Levels and Outcomes after Statin Therapy
Top Cited Papers
Open Access
- 6 January 2005
- journal article
- clinical trial
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 352 (1), 20-28
- https://doi.org/10.1056/nejmoa042378
Abstract
Statins lower the levels of low-density lipoprotein (LDL) cholesterol and C-reactive protein (CRP). Whether this latter property affects clinical outcomes is unknown.Keywords
This publication has 26 references indexed in Scilit:
- Statin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery DiseaseThe New England Journal of Medicine, 2005
- Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesCirculation, 2004
- Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary SyndromesThe New England Journal of Medicine, 2004
- Design of the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT)—TIMI 22 trialThe American Journal of Cardiology, 2002
- Effect of Statin Therapy on C-Reactive Protein LevelsJama-Journal Of The American Medical Association, 2001
- Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary EventsThe New England Journal of Medicine, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)Jama-Journal Of The American Medical Association, 2001
- Rapid Reduction in C-Reactive Protein With Cerivastatin Among 785 Patients With Primary HypercholesterolemiaCirculation, 2001
- Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive ProteinCirculation, 1999
- Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol LevelsCirculation, 1998